---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-058523"
form_type: "8-K"
ticker: "IMNM"
cik: "0001472012"
company_name: "Immunome Inc."
filed_at: "2025-06-11T23:59:59+00:00"
generated_at: "2026-05-19T12:57:03.712700+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Immunome stockholders elect Barchas and Bienaimé as Class II directors; ratify Ernst & Young

## Summary
- Isaac Barchas elected with 46.3M votes for, 15.2M withheld; Jean-Jacques Bienaimé elected with 47.1M for, 14.4M withheld.
- Stockholders ratified Ernst & Young as auditor for FY2025 with 76.3M votes for, 16K against.
- Broker non-votes totaled 14.7M on both director proposals; none on auditor ratification.
- Meeting held June 10, 2025; 87,011,822 shares outstanding and entitled to vote as of April 21 record date.

## SEC filing metadata
- accession: 0001104659-25-058523
- form_type: 8-K
- ticker: IMNM
- cik: 0001472012
- company_name: Immunome Inc.
- filed_at: 2025-06-11T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1472012/000110465925058523/0001104659-25-058523-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1472012/000110465925058523/tm2517681d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-058523
- JSON: https://secwatch.observer/filing/0001104659-25-058523.json
- Plain text: https://secwatch.observer/filing/0001104659-25-058523.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.